This compound is a quinazoline-diamine derivative used as an impurity reference standard in the quality control of afatinib, a pharmaceutical active ingredient.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Desfluoro-N-des(4-dimethylamino-2-en-1-oxo)butyl Afatinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(S)-N4-(3,4-Dichlorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine
pharmaceutical intermediate
(S)-N4-(4-Fluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine (Afatinib Impurity)
pharmaceutical raw material
(S,E)-N-(4-((3,4-Difluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide (Afatinib Impurity)
pharmaceutical raw material
Afatinib N-oxide
pharmaceutical raw material
Isavuconazole
pharmaceutical raw material
Isoconazole nitrate
pharmaceutical raw material
(RS)-econazole nitrate
pharmaceutical raw material
4-N-(3-chlorophenyl)-7-[(3S)-oxolan-3-yl]oxyquinazoline-4,6-diamine
VGCTYFLBQMFZEW-ZDUSSCGKSA-N
C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=CC=C4)Cl)N
—
Sourcing Desfluoro-N-des(4-dimethylamino-2-en-1-oxo)butyl Afatinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.